西施兰SISLAN品牌怎么样 申请店铺

我要投票 西施兰SISLAN在个人护理行业中的票数:554 更新时间:2025-12-14
西施兰SISLAN是哪个国家的品牌?「西施兰SISLAN」是西施兰(南阳)药业股份有限公司旗下著名品牌。该品牌发源于河南省南阳市,由创始人朱 * 华在1981年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力西施兰SISLAN品牌出海!将品牌入驻外推网,定制西施兰SISLAN品牌推广信息,可以显著提高西施兰SISLAN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

西施兰SISLAN怎么样

1981年,香港西施兰[西施兰(南阳)药业有限公司]以来料加工的方式来到河南南阳。伴随着改革开放的春风,1985年,西施兰公司[西施兰(南阳)药业有限公司]诞生,二十多年来栉风沐雨,自强不息,从小到大,由弱到强,取得了长足的发展,从一家资产200多万元、仅有一条生产线的小公司,发展成为资产上亿元的现代化集团企业。生产经营范围不仅涵盖药品、保健食品、日用化工产品、消毒产品等的研发、生产和销售,

“西施兰”品牌由刘崇庆先生发明,1981年在大陆注册,1983年在香港注册。

“西施兰夏露乌洛托品溶液(国药准字H41024617)”是公司的拳头产品,经国内多家机构临床验证,该药是一种止汗除臭剂,对腋臭、手脚多汗、脚癣等症有明显疗效,具有效果快速,用量小,用药间隔时间长,毒副作用小,使用方便、安全,用后可照常沐浴等特点。

“西施兰女性活力营养素”是一种天然生物制品,可调节女性生理机能,有效改善和消除女性更年期综合症等,是广大中老年女性美容、保健、保持女性魅力的好选择。

另一生物产品“西施兰灵芝孢子粉胶囊”,对提高人体免疫力,改善良性和恶性肿瘤有明显效果,市场前景十分广阔。

“西施兰止汗香体棒”的推出,真正解决了爱美人士和狐臭患者的一应烦恼,把止汗、除臭、香体的结合,既是“西施兰夏露”的姊妹篇,却更比“西施兰夏露”应用广泛。

为增强企业发展动力和保障,公司始终非常注重企业文化建设,在公司实施人性化、人情化管理机制,为全体员工创造了和谐、友爱的人文环境。

自建成以来,西施兰公司[西施兰(南阳)药业有限公司]一直保持良好的发展势头,年人均利税20多万元人民币,在河南三资企业中占据着重要地位。西施兰所取得的成绩,足可证明南阳的投资环境日益完善,也印证了祖国改革开放30年来所取得的伟大成就。2009年1 月,西施兰实现了发展中的新跨越,建筑面积30000平方米的新厂区一期项目正式建成投产。西施兰公司意气风发,阔步迈向集团化、多样化、自主研发和生产、销售一体化的现代化企业。


In 1981, Hong Kong xishlan [xishlan (Nanyang) Pharmaceutical Co., Ltd.] came to Nanyang, Henan Province by processing materials. With the spring breeze of reform and opening up, in 1985, xishlan company [xishlan (Nanyang) Pharmaceutical Co., Ltd.] was born. In the past 20 years, it has made great progress, from small to large, from weak to strong. It has developed from a small company with more than 2 million yuan of assets and only one production line to a modern group enterprise with more than 100 million yuan of assets. The production and business scope not only covers the R & D, production and sales of drugs, health food, daily chemical products, disinfection products, etc., "Xishi Lan" brand was invented by Mr. Liu Chongqing, registered in the mainland in 1981, and registered in Hong Kong in 1983. "Xishi lanxialu Urotropine solution (gjzz h41024617)" is the company's leading product. It has been clinically verified by many domestic institutions as an antiperspirant and deodorant. It has obvious curative effect on armpit odor, hyperhidrosis of hands and feet, tinea pedis and other diseases. It has the characteristics of quick effect, small dosage, long drug interval, small side effects, convenient and safe use, and bathing as usual after use 。 "Xishlan women's vitality nutrient" is a natural biological product, which can regulate women's physiological function, effectively improve and eliminate women's menopause syndrome, etc. it is a good choice for the majority of middle-aged and old women to beauty, health care and maintain their charm. Another biological product, xishlan ganoderma spore powder capsule, has obvious effect on improving human immunity, benign and malignant tumors, and has a broad market prospect. The launch of "xishelan antiperspirant stick" has really solved the problem of beauty lovers and patients with body odor. The combination of antiperspirant, deodorant and body odor is not only the sister of "xishelan Xialu", but also more widely used than "xishelan Xialu". In order to enhance the power and guarantee of enterprise development, the company has always attached great importance to the construction of enterprise culture, implemented humanized and humanized management mechanism in the company, and created a harmonious and friendly human environment for all employees. Since its establishment, xishlan company [xishlan (Nanyang) Pharmaceutical Co., Ltd.] has maintained a good momentum of development, with an annual per capita profit and tax of more than 200000 yuan, occupying an important position among the three capital enterprises in Henan Province. The achievements of xishlan can prove that Nanyang's investment environment is improving day by day and the great achievements of the reform and opening up of the motherland in the past 30 years. In January 2009, xishelan realized a new leap in development, and the first phase of the new plant area with a building area of 30000 square meters was officially completed and put into operation. Xishlan company is full of spirit and strides forward to a modern enterprise with collectivization, diversification, independent R & D, production and sales integration.

本文链接: https://brand.waitui.com/0461d6279.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

2025年人工智能核心产业规模有望破万亿元

12月14日,从中国信息通信研究院了解到,今年以来,我国人工智能产业呈加速发展态势,2025年人工智能核心产业规模有望突破万亿元。数据显示,今年以来,生产制造环节的大模型应用增长显著,应用案例占比由去年的19.9%增长至25.9%,带动人工智能产业规模快速增长。(央视新闻)

2小时前

近一周逾260家公司获机构调研 中科曙光和海光信息获调研数最多

近一周获得机构调研的个股有260多只,中科曙光和海光信息调研机构数最多。中科曙光和海光信息近一周有341家机构调研。中科曙光方面表示,尽管重组终止,但海光与曙光仍将在保持上市公司独立性基础上深化协同。安克创新、伟创电气等个股也均获得逾百家机构调研。从市场表现来看,近一周机构调研股月内平均上涨近1%。超捷股份、霍莱沃、斯瑞新材、博盈特焊、华菱线缆等个股均涨逾20%。(人民财讯)

2小时前

调查:美联储明年1月降息25个基点的概率为24.4%

12月14日,据CME“美联储观察”:美联储2026年1月降息25个基点的概率为24.4%,维持利率不变的概率为75.69%。美联储到明年3月累计降息25个基点的概率为41.4%,维持利率不变的概率为50.5%,累计降息50个基点的概率为8.1%。(界面新闻)

2小时前

万科三个展期议案均未获通过 仍有5个工作日宽限期

12月13日公告显示,万科“22万科MTN004”持有人会议三项展期议案均未获有效通过,核心展期规则均为展期一年且期间不付本息,差异在增信安排。议案一未设增信,无人同意;议案二增信加调整本息兑付,获83.40%同意;议案三仅一票同意。万科还有5个工作日宽限期谈判。(新浪财经)

2小时前

2030年我国天然气产量将达3000亿立方米

《中国油气行业“十四五”发展成就报告》显示,中国正加速迈向现代油气产业发展新阶段,能源结构日趋多元均衡,2030年我国天然气产量将达到3000亿立方米。报告显示,“十四五”期间我国累计新增探明地质储量石油70亿吨、天然气7万亿立方米,分别较“十三五”增长约43%、40%,油气产量创历史新高。(央视新闻)

2小时前

本页详细列出关于西施兰SISLAN的品牌信息,含品牌所属公司介绍,西施兰SISLAN所处行业的品牌地位及优势。
咨询